Protocol comparisons have shown that different BG targets were used, there were differences in study populations, differences in definitions of hypoglycemia, all of which contributed to wide disparities in the performances of IV insulin protocols thereby precluding reasonable comparisons in efficacy of therapy and outcomes [13,14,17-20]. Here, INS is linked to Hypoglycemia.